Third Harmonic Bio, Inc. (THRD) Price & Analysis

Compare

31 Followers

THRD Stock Chart & Stats

Day’s Range― - ―

52-Week Range$3.18 - $16.02

Previous CloseN/A

Volume85.60K

Average Volume (3M)265.66K

Market Cap

$245.04M

Enterprise Value-$115.22M

Total Cash (Recent Filing)$271.61M

Total Debt (Recent Filing)$3.00M

Price to Earnings (P/E)―

Beta-0.08

Next Earnings

Aug 07, 2025

EPS Estimate

-0.23

Last Dividend Ex-Date

Aug 06, 2014

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.35

Shares Outstanding45,127,796

10 Day Avg. Volume256,523

30 Day Avg. Volume265,664

Financial Highlights & Ratios

PEG Ratio-0.18

Price to Book (P/B)0.59

Price to Sales (P/S)0.00

P/FCF Ratio-4.84

Enterprise Value/Market Cap-0.47

Enterprise Value/Revenue-68.91

Enterprise Value/Gross Profit9.60K

Enterprise Value/Ebitda0.55

Forecast

1Y Price Target

$5.23

Price Target Upside-3.68% Downside

Rating ConsensusHold

Number of Analyst Covering2

Third Harmonic Bio, Inc. News

PremiumThe Fly

Third Harmonic Bio receives stockholder approval of plan of liquidation

18d ago

THRD

PremiumThe Fly

Third Harmonic Bio reports updated THB335 data, initiates THB335 sale

18d ago

THRD

PremiumCompany Announcements

Third Harmonic Bio Approves Liquidation and Dissolution Plan

18d ago

THRD

PremiumCompany Announcements

Third Harmonic Bio Approves Key Proposals at Annual Meeting

19d ago

THRD

PremiumCompany Announcements

Third Harmonic Bio Reports Q1 2025 Financial Results

1M ago

THRD

PremiumCompany Announcements

Third Harmonic Bio’s CSO Christopher Dinsmore Steps Down

2M ago

THRD

PremiumThe Fly

Biotech Alert: Searches spiking for these stocks today

3M ago

PTN

ARTL

PremiumRatings

Third Harmonic Bio, Inc. Liquidation and Shareholder Distribution: Analyst Maintains Hold Rating Amid Strategic Uncertainties

3M ago

THRD

See All THRD News

See All News >

Bulls Say, Bears Say

Bulls Say

Financial PositionThird Harmonic ended the fourth quarter of 2024 with $285 million in cash, which is expected to support operations at least through 2026.

Research And DevelopmentTHB335 demonstrated strong pharmacokinetics and pharmacodynamics with deep serum tryptase reductions.

Bears Say

Company StrategyThird Harmonic Bio announced plans to liquidate and dissolve the company.

Safety ConcernsSafety concerns from Phase 1 data, including reductions in hemoglobin and neutrophils, likely limit the use of higher doses of THB335.

Stock RatingThe stock rating for THRD has been downgraded to Hold due to a lack of clarity on the development path for THB335.

Financials

Income Statement >

Options Prices

Detailed Option Prices >

Ownership Overview

37.63% Insiders

12.10% Mutual Funds

<0.01% Other Institutional Investors

45.16% Public Companies and

Individual Investors

Detailed Ownership Overview >

THRD FAQ

What was Third Harmonic Bio, Inc.’s price range in the past 12 months?

Third Harmonic Bio, Inc. lowest stock price was $3.18 and its highest was $16.02 in the past 12 months.

What is Third Harmonic Bio, Inc.’s market cap?

Third Harmonic Bio, Inc.’s market cap is $245.04M.

When is Third Harmonic Bio, Inc.’s upcoming earnings report date?

Third Harmonic Bio, Inc.’s upcoming earnings report date is Aug 07, 2025 which is in 38 days.

How were Third Harmonic Bio, Inc.’s earnings last quarter?

Third Harmonic Bio, Inc. released its earnings results on May 08, 2025. The company reported -$0.352 earnings per share for the quarter, missing the consensus estimate of -$0.245 by -$0.107.

Is Third Harmonic Bio, Inc. overvalued?

According to Wall Street analysts Third Harmonic Bio, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Third Harmonic Bio, Inc. pay dividends?

Third Harmonic Bio, Inc. pays a Quarterly dividend of $0.12 which represents an annual dividend yield of N/A. See more information on Third Harmonic Bio, Inc. dividends here

What is Third Harmonic Bio, Inc.’s EPS estimate?

Third Harmonic Bio, Inc.’s EPS estimate is -0.23.

How many shares outstanding does Third Harmonic Bio, Inc. have?

Third Harmonic Bio, Inc. has 45,127,796 shares outstanding.

What happened to Third Harmonic Bio, Inc.’s price movement after its last earnings report?

Third Harmonic Bio, Inc. reported an EPS of -$0.352 in its last earnings report, missing expectations of -$0.245. Following the earnings report the stock price went up 0.195%.

Which hedge fund is a major shareholder of Third Harmonic Bio, Inc.?

Currently, no hedge funds are holding shares in THRD

Third Harmonic Bio, Inc. Stock Smart Score

Underperform

Fundamentals

Return on Equity

-19.94%

Trailing 12-Months

Asset Growth

3.44%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Third Harmonic Bio, Inc.

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.

THRD Stock 12 Month Forecast

Average Price Target

$5.23

▼(-3.68%Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","15":"$15","5.25":"$5.25","8.5":"$8.5","11.75":"$11.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5.23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.23</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$5.23</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.23</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,5.25,8.5,11.75,15],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2024","6":"Aug<br/>2024","9":"Jan<br/>2025","12":"Apr<br/>2025","25":"Apr<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.36,3.503846153846154,3.647692307692308,3.7915384615384617,3.9353846153846153,4.07923076923077,4.223076923076923,4.366923076923078,4.510769230769231,4.654615384615385,4.798461538461539,4.9423076923076925,5.086153846153847,{"y":5.23,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.36,3.503846153846154,3.647692307692308,3.7915384615384617,3.9353846153846153,4.07923076923077,4.223076923076923,4.366923076923078,4.510769230769231,4.654615384615385,4.798461538461539,4.9423076923076925,5.086153846153847,{"y":5.23,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.36,3.503846153846154,3.647692307692308,3.7915384615384617,3.9353846153846153,4.07923076923077,4.223076923076923,4.366923076923078,4.510769230769231,4.654615384615385,4.798461538461539,4.9423076923076925,5.086153846153847,{"y":5.23,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.85,"date":1690848000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.5,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.73,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.3,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.38,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.31,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.74,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.33,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.42,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.29,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.26,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.45,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.36,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >